Literature DB >> 20574773

Radiosurgery of liver tumors: value of robotic radiosurgical device to treat liver tumors.

Sebastian Stintzing1, Ralf-Thorsten Hoffmann, Volker Heinemann, Markus Kufeld, Markus Rentsch, Alexander Muacevic.   

Abstract

BACKGROUND: The treatment of isolated liver metastases has become a rapidly developing field with many new, technically advanced methods. Here we present the therapeutic efficacy of a robotic radiosurgery for local control of liver metastases from solid tumors.
METHODS: Patients with tumorous lesions to the liver, not qualifying for surgery, were treated with single-session radiosurgery (24 Gy) that used robotic image-guided real-time tumor tracking. All detectable lesions had to be irradiated. In a prospective analysis, follow-up was performed by magnetic resonance imaging scanning 2 months after the treatment, and subsequently at 3-month intervals to evaluate local control. For inclusion into the radiosurgery treatment protocol, tumor volumes had to be <90 ml.
RESULTS: Thirty-six patients (median age, 65 years) with a total of 54 target lesions were evaluated. Single lesions were treated in 23 patients and multiple targets in 13 patients. Metastases originated from colon cancer (n = 19), ovarian cancer (n = 3), pancreatic cancer (n = 2), breast cancer (n = 2), and others (n = 6). Four lesions were of primary liver origin (hepatocellular carcinoma and cholangiocellular carcinoma). Median tumor volume was 18 ml (range, 2.2-90 ml). The median follow-up was 21.3 months. The disease of 25 patients (69.4%) showed complete or partial local response, 6 patients (16.7%) had stable lesions, and 5 patients (14%) experienced local recurrence. Grade 2-4 adverse events due to radiation treatment were not observed.
CONCLUSIONS: Robotic radiosurgery with image-guided real-time tumor tracking of liver neoplasm is a new and promising approach for patients with disease that is not eligible for surgical resection and might enhance the possibilities of multidisciplinary oncological treatment concepts.

Entities:  

Mesh:

Year:  2010        PMID: 20574773     DOI: 10.1245/s10434-010-1187-9

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  11 in total

1.  Stereotactic radiosurgery for brain metastases from hepatocellular carcinoma.

Authors:  Jung Ho Han; Dong Gyu Kim; Hyun-Tai Chung; Sun Ha Paek; Chul-Kee Park; Chae-Yong Kim; Young-Hoon Kim; Hee-Won Jung
Journal:  J Neurooncol       Date:  2013-06-29       Impact factor: 4.130

2.  Stereotactic body radiation therapy for liver metastases: Clinical outcomes and literature review.

Authors:  Cuauhtémoc de la Peña; María F Gonzalez; César González; Joel M Salazar; Benjamín Cruz
Journal:  Rep Pract Oncol Radiother       Date:  2020-05-23

3.  Stereotactic body radiation therapy using the CyberKnife(®) system for patients with liver metastases.

Authors:  Zhi-Yong Yuan; Mao-Bin Meng; Chun-Lei Liu; Huan-Huan Wang; Chao Jiang; Yong-Chun Song; Hong-Qing Zhuang; Dong Yang; Jing-Sheng Wang; Wang Wei; Feng-Tong Li; Lu-Jun Zhao; Ping Wang
Journal:  Onco Targets Ther       Date:  2014-06-12       Impact factor: 4.147

4.  Clinical results of mean GTV dose optimized robotic guided SBRT for liver metastases.

Authors:  Nicolaus Andratschke; Alan Parys; Susanne Stadtfeld; Stefan Wurster; Stefan Huttenlocher; Detlef Imhoff; Müjdat Yildirim; Dirk Rades; Claus Michael Rödel; Jürgen Dunst; Guido Hildebrandt; Oliver Blanck
Journal:  Radiat Oncol       Date:  2016-05-28       Impact factor: 3.481

Review 5.  Strategies to tackle the challenges of external beam radiotherapy for liver tumors.

Authors:  Michael I Lock; Jonathan Klein; Hans T Chung; Joseph M Herman; Edward Y Kim; William Small; Nina A Mayr; Simon S Lo
Journal:  World J Hepatol       Date:  2017-05-18

6.  The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases.

Authors:  N Andratschke; H Alheid; M Allgäuer; G Becker; O Blanck; J Boda-Heggemann; T Brunner; M Duma; S Gerum; M Guckenberger; G Hildebrandt; R J Klement; V Lewitzki; C Ostheimer; A Papachristofilou; C Petersen; T Schneider; R Semrau; S Wachter; D Habermehl
Journal:  BMC Cancer       Date:  2018-03-13       Impact factor: 4.430

7.  Long-term Survival in Patients Treated with a Robotic Radiosurgical Device for Liver Metastases.

Authors:  Sebastian Stintzing; Jobst von Einem; Christoph Fueweger; Alfred Haidenberger; Michael Fedorov; Alexander Muavcevic
Journal:  Cancer Res Treat       Date:  2018-04-16       Impact factor: 4.679

8.  Frameless Single Robotic Radiosurgery for Pulmonary Metastases in Colorectal Cancer Patients.

Authors:  Jobst C Von Einem; Sebastian Stintzing; Dominik P Modest; Michael Wiedemann; Christoph Fürweger; Alexander Muacevic
Journal:  Cureus       Date:  2020-03-18

9.  CyberKnife Radiosurgery - Value as an Adjunct to Surgical Treatment of HCC?

Authors:  Markus Schoenberg; Andrey Khandoga; Sebastian Stintzing; Christoph Trumm; Tobias Simon Schiergens; Martin Angele; Mark Op den Winkel; Jens Werner; Alexander Muacevic; Markus Rentsch
Journal:  Cureus       Date:  2016-04-28

Review 10.  Current and Future Treatment of Hepatocellular Carcinoma: An Updated Comprehensive Review.

Authors:  Saleh Daher; Muhammad Massarwa; Ariel A Benson; Tawfik Khoury
Journal:  J Clin Transl Hepatol       Date:  2017-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.